Context Therapeutics Inc (CNTX) Stock Price, Quote, News & History

CNTXNASDAQ
$0.6300
0.0142.27%
At close: Jul 21, 5:00 PM EST
$0.6265
-0.0035-0.56%
After Hours: 7:56 PM EST
Loading...

Key Statistics

Open
$0.62
Close
$0.63
Volume / Avg.
1.16M / 2.26M
Day Range
$0.61 - $0.64
52 Wk Range
0.55 - 3.62
Market Cap
$57.56M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
32
Short Interest
4.03%
Days to Cover
1

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-32.79M
Investing Cash Flow (TTM)
-2.04M
Financing Cash Flow (TTM)
0
Free Cash Flow (TTM)
-34.82M
Capital Expenditure (TTM)
-2.04M
Net Change in Cash (TTM)
-34.82M

Analyst Trends and Forecast

3
Mar
1
Jun
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$2.35M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
1.08
Earnings Yield % (TTM)
-68.18%
Earnings Yield % (FWD)
-66.56%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.57

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$54.53M
Debt to Equity
0.01
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$0.62
Close
$0.63
Volume / Avg.
1.16M / 2.26M
Day Range
$0.61 - $0.64
52 Wk Range
0.55 - 3.62
Market Cap
$57.56M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
32
Short Interest
4.03%
Days to Cover
1

About

Sector
Health Care
Industry
Pharmaceuticals
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, includin...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Context Therapeutics (CNTX) stock?

A

You can purchase shares of Context Therapeutics (NASDAQ:CNTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Context Therapeutics (CNTX) competitors?

A

There are no as such competitors for Context Therapeutics.

Q

What is the forecast, or price target, for Context Therapeutics (CNTX) stock?

A

Context Therapeutics has a consensus price target of $5.69.

Q

What is the current price for Context Therapeutics (CNTX)?

A

The stock price for Context Therapeutics (NASDAQ: CNTX) is $0.6265 last updated July 21, 2026 at 7:56 PM EDT.

Q

Does Context Therapeutics (CNTX) pay a dividend?

A

There are no upcoming dividends for Context Therapeutics.

Q

When is Context Therapeutics (NASDAQ:CNTX) reporting earnings?

A

Context Therapeutics does not have any upcoming earnings scheduled.

Q

Is Context Therapeutics (CNTX) going to split?

A

There is no upcoming split for Context Therapeutics.

Q

What sector and industry does Context Therapeutics (CNTX) operate in?

A

Context Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.